Credit Suisse Maintains Neutral Rating for Cross Country Healthcare: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Credit Suisse has maintained its Neutral rating for Cross Country Healthcare (NASDAQ:CCRN) but lowered its price target from $27.00 to $26.00. Cross Country Healthcare's shares are currently trading up 1.89% over the last 24 hours, at $22.61 per share. A move to $26.00 would account for a 14.99% increase from the current share price.
August 08, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Credit Suisse has maintained its Neutral rating for Cross Country Healthcare but lowered its price target. This could potentially impact the stock's performance in the short term.
The decision by Credit Suisse to maintain a Neutral rating indicates that they do not foresee significant changes in the stock's performance. However, the lowering of the price target could potentially indicate a less optimistic outlook, which may impact investor sentiment and the stock's performance in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100